Taking PJT/EVR RX over GS/JPM/MS?
Title explains it quite well, been very fortunate to have received an offer for a summer analyst position from both firm types. I already have experience at one of the three BB and want to have a "fun" and strong learning experience over the summer.
Currently leaning towards the EB offer as I would see something new and they apparently have a better culture. However, I'm scared that the brand of the BBs would be much more useful for Corporate (interested in CFO roles) or PE (interested in funds like BX TacOpps or Apollo Hybrid value) roles.
What do you guys think?
MS is on a major decline so take the other offers if MS is one of the options - they don’t have the same reputation anymore.
Take PJT/EVR RX if that’s the option. Top group and placement. Will open doors.
Just curious, what makes you say MS is on the decline? Are they still a top bank?
Yes they are still a top bank but since you already have BB experience it would be nice to try an EB. RX learning opportunities are really good.
Yes still a top bank but the gap between GS/JPM and MS is widening each year.
The timing just doesn’t match either for US or London. Just focus on getting the offers once recruiting rolls around in Jan bro instead of this mental masturbation. FYI idk a single person in EB Rx that was remotely even interested in any BB.
This is for London, the timing matches. Thanks for the insight into the RX view over BB!
If you are in London the dynamic is reversed. PJT is not guaranteed to be in RSSG and EVR Rx is still in growth mode. Only people who are truly into distressed are doing EB Rx in London as opposed to NYC where its mostly ppl dead set on MFPE. Would not pick EB Rx over GS/MS/JPM in London unless you know for a fact you want to do special sits investing.
del
If you're looking to try something new and the EB has a better culture, that could make for a more enjoyable and eye-opening summer. That said, BBs do carry strong brand power, especially for corporate roles or bigger PE names.
For buyout PE, PJT/EVR RX wiped even the top GS/MS groups this year (TMT/FIG, M&A/M&C). Essentially everyone who seriously wanted it is going to MFPE (with a couple UMMs).
Have been seeing inaccurate comments recently to do top BB over top RX if you want buyout - despite what incoming WSO interns say, the data overwhelmingly favors RX. Especially when you adjust for group size (PJT/EVR are ~10), placement is simply not comparable
Edit: To the below poster's point, this is for NYC. Don't know anything about London
He is in London. Dynamics are very different there
When you say that you had experience at one of the three BB do you mean you done a spring week at JPM/MS?
No, was an off-cycle intern (in one of the european offices)
Okay that makes more sense, I was going to say how can you understand the culture / work of a BB if you haven't spent a long time there.
Nice to hear your views on BBs
If you are taking this time to ask WSO I would argue it has to be GS over all.
Mind I pm you?
Deleniti sapiente sit nostrum est quo ut. Dolor omnis illum inventore itaque et. Eos et ut quia numquam esse praesentium. Quisquam beatae a eos similique.
Labore similique sapiente iste rerum molestias dicta. Velit quam architecto nostrum est eum rerum ut. Harum quisquam et assumenda ex sit sint reprehenderit.
Ratione recusandae doloremque unde molestiae. Temporibus sequi non officia qui iure excepturi eum. Voluptatem iure illo maxime doloremque.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...